Protara Therapeutics Cash Flow Statement (2013-2026) | TARA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-12.78M-10.78M-10.23M-10.76M-8.19M-7.69M-38.88M-9.13M-11.29M-9.86M-10.22M-11.10M-9.53M-11.22M-14.00M-12.57M-15.36M-13.26M-18.91M-17.97M
Depreciation and Depletion (Quarter)
0.06M-0.02M0.05M0.06M0.05M0.06M0.07M0.08M0.08M0.08M0.11M0.08M0.08M0.08M0.08M0.08M0.10M0.09M0.09M0.09M
Share-based Compensation (Quarter)
3.00M2.72M1.91M1.88M1.94M1.44M1.43M1.57M1.62M1.45M1.45M1.23M1.06M0.93M0.90M0.64M0.90M1.05M1.04M0.95M
Gains from Sales and Divestitures (Quarter)
0.13M0.17M0.19M0.03M0.06M0.09M0.10M0.11M0.11M0.11M0.13M0.13M0.13M0.13M
Gains from Investment Securities (Quarter)
0.67M0.01M1.83M1.98M1.83M0.01M0.00M0.03M2.90M0.05M1.50M3.83M5.69M4.91M1.74M1.64M1.70M0.01M
Non-cash Items (Quarter)
0.33M12.600.59M0.76M0.10M1.09M1.20M0.02M3.67M0.17M1.82M8.98M4.22M1.30M5.05M8.98M8.84M
Cash from Operations (Quarter)
-9.47M-6.20M-6.91M-10.96M-5.12M-5.35M-5.03M-12.89M-9.41M-6.56M-8.70M-10.38M-7.69M-8.43M-9.31M-14.71M-12.25M-12.45M-16.95M-21.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.12M0.31M0.34M0.41M0.27M0.35M0.11M-0.07M0.75M0.03M-1.16M0.25M0.25M0.25M-1.44M0.26M-0.80M-0.40M2.01M-0.19M
Depreciation & Amortization (CF) (Quarter)
0.06M-0.02M0.05M0.06M0.05M0.06M0.07M0.08M0.08M0.08M0.11M0.08M0.08M0.08M0.08M0.08M0.10M0.09M0.09M0.09M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
-0.45M-0.47M0.03M-0.41M-0.15M0.06M1.13M2.50M-2.23M0.65M-0.07M-1.46M0.41M0.91M1.52M-1.50M2.99M-0.80M-1.56M1.09M
Change in Accured Expenses (Quarter)
0.07M0.48M-1.01M-1.04M0.38M0.53M-1.19M-1.84M0.73M1.17M-0.57M0.80M-0.30M2.04M0.14M-1.87M-0.28M0.92M2.04M-2.60M
Investing Activities
Capital Expenditures (Quarter)
0.33M-0.06M0.04M0.01M0.02M0.08M0.01M0.01M0.00M0.04M0.01M0.04M0.02M0.00M0.02M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
19.13M10.78M22.05M22.35M6.42M14.52M23.10M3.00M22.50M7.50M4.00M17.91M35.82M29.14M
Cash from Investing Activities (Quarter)
-1.94M0.11M1.89M0.74M13.50M19.05M-18.34M9.86M22.35M6.38M14.52M23.10M2.94M-29.39M22.50M-58.35M-47.72M-6.51M-26.91M-14.72M
Financing Activities
Other financing activities (Quarter)
1.64M1.41M1.36M1.56M1.55M1.15M1.15M1.26M1.29M1.17M1.16M0.39M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Short-Term Debt issuances (Quarter)
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.00M0.02M1.94M
Shares Repurchased (Quarter)
0.07M0.02M0.31M0.33M0.28M1.12M0.15M0.11M0.11M0.11M0.12M0.17M0.20M0.20M0.32M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.07M-0.02M-0.06M-0.03M-0.08M42.09M97.85M1.73M0.01M0.01M80.96M1.14M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-11.41M-6.09M-5.02M-10.29M8.38M13.68M-23.37M-3.09M12.94M-0.21M5.82M12.64M37.35M-37.82M111.04M-71.34M-59.97M-18.95M37.11M-34.92M
Free Cash Flow (Quarter)
-9.80M-6.14M-6.95M-10.97M-5.14M-5.43M-5.03M-12.89M-9.41M-6.60M-8.70M-10.38M-7.69M-8.44M-9.31M-14.76M-12.27M-12.46M-16.97M-21.34M
Net Cash Flow (Quarter)
-11.41M-6.09M-5.02M-10.29M8.38M13.68M-23.37M-3.09M12.94M-0.21M5.82M12.64M37.35M-37.82M111.04M-71.34M-59.97M-18.95M37.11M-34.92M